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Abstract
Background: The hypothalamus has been discussed as a pivotal structure for both cluster headache (CH) and aggres-
siveness, but little is known about the extent of self-reported aggressiveness in patients with CH.
Patients and methods: Twenty-six patients with chronic, 25 with active episodic and 22 with episodic CH outside the active
period were examined interictally with a validated questionnaire quantifying factors of aggression and compared with 24
migraine patients and 31 headache-free volunteers.
Results: The ANOVA was significant for the subscale ‘self-aggression/depression’ (F4, 123¼ 5.771, p< 0.001) with signifi-
cant differences between chronic and episodic CH and healthy volunteers. No significant changes were found for other
subscales and the sum scale (F4, 123< 1.421, p> 0.230). Especially in the clinically most affected group of patients (chronic
CH and active episodic CH), high levels of ‘‘self-aggression/depression’’ correlate with higher prevalence of depressive
symptoms and higher impairment measured on an emotional and functional level.
Discussion: Self-aggressive and depressive cognitions with highest scores in chronic CH seem to be reactive as they
correlate with depressive symptoms and impairment. They should be considered as an important therapeutic target
since they impair the patient’s life significantly.
Keywords
Cluster headache, migraine, aggression, hypothalamus, FAF, impairment
Date received: 26 October 2011; accepted: 26 February 2012
Introduction
Cluster headache (CH) is a severe and disabling condi-
tion characterized by excruciating unilateral pain
attacks located mainly in the ﬁrst trigeminal division
lasting between 15 and 180 minutes (1). Attacks are
accompanied by striking ipsilateral signs of parasympa-
thetic activation and sympathetic hypoactivity (2) and
lead to signiﬁcant impairment (3,4). As many as 90% of
patients report restlessness, with visible motor symp-
toms such as pacing around, rocking or agitation (5).
Patients often report further behavioural peculiarities
ranging from complex stereotyped actions to seeking
seclusion and often even refuse to see their family mem-
bers. Self-inﬂicted injuries (such as banging their head
or knocking their ﬁsts against a wall), and other
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self-aggressive respectively self-mutilating behaviour
have also been reported (5–8). The rate of self-inﬂicted
traumatic head injuries is reported to be higher in
patients with CH than in migraine, especially for
brawls (9). However, increased aggressiveness towards
others has never been described as a typical ﬁnding and
is mentioned only anecdotally (10–12).
Aggressiveness is a complex phenomenon and can be
a correlate of other underlying disorders such as
depression and pain (13,14). As previous studies have
reported signiﬁcant psychiatric symptoms in patients
with CH (4,15–17), higher levels of aggression – if pre-
sent – could be explained by this concomitant spectrum
of disease. From a pathophysiological perspective,
there is good evidence for the involvement of the
ventro- and dorsomedial as well as the posterior hypo-
thalamus in the pathophysiology of aggression (18).
Interventional data from animal experiments (19) and
stereotactic neurosurgery of the posterior hypothalamic
region in humans (20) have shown striking eﬀects on
aggressive behaviour. However, aggression cannot be
reduced to the hypothalamic system alone. Extensive
changes in neurotransmitter release have been
described in an intricate network of areas such as the
orbitofrontal and the anterior cingulate cortex
(top-down control) and limbic structures, mainly the
amygdala (21).
It is intriguing that neuroimaging studies have found
morphological and functional changes in the posterior
hypothalamus in patients with CH (22,23) as well, sug-
gesting a role in the pathophysiology of CH. This is
supported by the eﬃcacy of deep brain stimulation of
the posterior hypothalamus in medically intractable
CH (24–26).
It is not known whether patients with CH have higher
levels of aggression compared to other primary head-
aches and healthy volunteers. In addition, it is unknown
whether these changes are conﬁned to acute attacks as a
facet of intermittent hypothalamic activation or active
periods (as a transient state). Alternatively, they could
be constantly present as personality traits.
The aim of the study was therefore to answer the
following questions in a prospective and controlled
multicentre study:
1. Do patients with episodic CH in the active period,
episodic CH outside the active period, or chronic
CH show higher degrees of interictal aggression
and its submodalities compared to patients with
migraine and healthy volunteers?
2. Is there any relationship between aggression scores
and depressive symptoms?
3. Is there any relationship between aggression scores
and headache-speciﬁc emotional and functional
impairment?
Patients and methods
Patients
Headache patients were recruited at three sites in
Germany (University Hospital Regensburg,
University Hospital Halle, Kiel Pain Headache
Center). The study focusing on aggression was part of
a larger study on epidemiological and clinical aspects of
CHs. Data on impairment due to headache have been
published elsewhere (4). Patients were examined by an
experienced headache specialist and diagnosed accord-
ing to the current ICHD-II criteria for migraine with-
out and with aura (IHS 1.1 and 1.2) and for episodic
(ECH, IHS 3.1.1) and chronic cluster headache (CCH,
IHS 3.1.2.). Ninety-seven headache patients were
included in total with the following subgroups: 27
patients with chronic CH, 26 with episodic CH in the
active period (ECHa), 22 with episodic CH outside the
active period (ECHi) and 24 patients with migraine
(MIG; 8 patients with visual aura, i.e. 33% and one
from sensory aura, i.e. 4%). Details are shown in
Table 1. Thirty-one healthy volunteers without any his-
tory of primary headache disorders were recruited as a
healthy control group (HC). All subjects gave written
informed consent. The study was approved by the lead
ethics committee of the University of Regensburg as
well as the local ethics committees and was in compli-
ance with the Declaration of Helsinki (2008).
Study design
All participants completed a face-to-face standardized
interview to screen for psychiatric disorders (axis I),
which is used widely in Germany (Mini-DIPS) (27).
Responses to screening questions indicative for depres-
sive syndrome were explored. Afterwards, subjects
were asked to complete a questionnaire assessing mod-
alities of aggression (FAF; see below for further infor-
mation) and return it in a sealed envelope to
minimize under-reporting as a modiﬁcation of the
sealed envelope approach (28). To ensure that data
was collected interictally and to avoid loss of data
patients were requested to complete all questionnaires
in the clinic.
Questionnaire for Measuring Factors of Aggression
(FAF)
This questionnaire reliably assesses various modalities
of aggressive behaviour with 77 items. Subjects
aﬃrmed or negated FAF items in a dichotomous
fashion (‘Occasionally I lose my temper and become
angry’: yes or no) (29). The FAF evaluates ﬁve dimen-
sions of aggressive behaviour: 1 spontaneous aggres-
sion (thoughts about aggression against others); 2
Luerding et al. 529
reactive aggression (degree of socially accepted self-
assertion); 3 irritability (tolerance to frustration); 4
self-aggression/depression (dissatisfaction with own
personality, self-reproach); and 5 inhibition of aggres-
sion (ability to regulate aggressive thoughts). A sum
score can be calculated for the ﬁrst three scales. The
FAF shares some items with the Freiburg Personality
Inventory and is partly based on the American Buss
Durkee Hostility Inventory (30). A simple translation
of the latter would not have adequately addressed cul-
tural peculiarities for a German-speaking population.
German FAF norms were established in 630 subjects
(males and females ranging from 15 to 75 years of age).
The construct was validated in juvenile and adult delin-
quents who showed signiﬁcantly increased scores for
the scales 1 (spontaneous aggression), 3 (irritability), 4
(self-aggression/depression) and the sum score com-
pared to the sample drawn from the general popula-
tion. The scales do not correlate with the general
intelligence quotient measured by the Wechsler Adult
Intelligence Scale. The internal consistency (Cronbach’s
a) diﬀers between 0.61 and 0.79 for the subscales and
reaches 0.85 for the sum score. The split-half reliability
(Spearman–Brown) reaches 0.857.
Adult delinquents (n¼ 77) showed signiﬁcant diﬀer-
ences in the irritability and self-aggression scales and in
the sum of aggression scales in comparison to controls.
The diﬀerence in self-aggression was attributed to the
consequences of the imprisonment. Hampel and Selg
(29) also report that the spontaneous aggression scale
reached higher scores in psychiatric patients than in
psychosomatic patients, lower scores in reactive aggres-
sion for both groups and higher scores for both patient
groups in the irritability and the self-aggression scales.
For the inhibition scale higher scores were found in
psychiatric patients, whereas psychosomatic patients
scored lower.
Because of this sensitivity to diﬀerent aspects of
aggressive behaviour, the questionnaire has been used
widely in German-speaking populations in various
clinical and non-clinical contexts. It was used to meas-
ure the relationship between aggression and allergic
disorders (31,32), rheumatoid arthritis (33) and
patients with hand dermatitis (34). Additionally, the
FAF was used to correlate behaviour with speciﬁc
genotypes in psychiatric patients (35–39) and in person-
ality diagnostics in Austrian (40) and Swiss psychiatric
patients (41).
Headache Disability Inventory (HDI)
All participants completed the German adaptation of
the 25-item Henry Ford Hospital Headache Disability
Inventory (HDI) (42,43) with a ‘total’ score and two
subscores (EMOTION with 13 items for the inﬂuence
of headache on mood) and FUNCTION (12 items to
detect restrictions in activities of daily living). Detailed
results can be found elsewhere (4).
Statistics
Data were analysed with SPSS 18 for Windows (SPSS;
Chicago, IL, USA). The scores of the six subscales and
the sum scale were entered separately in univariate ana-
lyses of variance (ANOVAs) with the between-factor
‘group’. If variance homogeneity was violated, eﬀects
were veriﬁed by means of non-parametric Kruskal–
Wallis H-test. Post hoc tests were used to further inves-
tigate signiﬁcant main eﬀects. Bonferroni correction
was used to correct for multiple testing (10 comparisons
required puncorrected< 0.005 to achieve global p< 0.05).
When necessary for detailed understanding of results
non-corrected least signiﬁcant diﬀerences are reported
(i.e. puncorrected< 0.05).
Table 1. Clinical details of patients included and results. Results on depressive symptoms have been published as part of a previous
study (17)
CCH ECHa ECHi MIG Control
Number 27 26 22 24 31
Age (years) 42.1 41.3 40.6 37.4 38.4
Gender (male:female) 4.4:1 5.5:1 1.8:1 1:3.8 1.1:1
Duration of disease (years) 11.4 12.0 12.6 13.6 –
Age of onset (years) 30.6 29.4 28.2 23.8 –
Mean FAF sum score (SD) 10.0 ( 8.1) 9.2 ( 5.5) 7.6 ( 6.4) 7.9 ( 5.5) 6.7 ( 3.7)
Depressive symptoms in the past 15 (56%) 7 (27%) 8 (36%) 7 (29%) 6 (19%)
CCH: chronic cluster headache; ECHa: episodic cluster headache in the active phase; ECHi: episodic cluster headache outside the active period; MIG:
migraine; Control: healthy controls; SD: standard deviation; FAF: Questionnaire for Measuring Factors of Aggression. One subject each in the CCH and
ECHa group did not complete the FAF questionnaire.
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Further analyses tested if revealed that a linear
model would ﬁt best to detect a polynomial contrast
despite non-signiﬁcant main eﬀects (such as a linear
increase or decrease in a measure from the chronic
CH patients over other patient groups to healthy con-
trols). We thus applied a polynomial linear contrast
weighting groups (2 1 0 –1 –2) in the expected order
(CCH, ECHa, ECHi, MIG, HC). As we had
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Figure 2. Mean FAF subscores in all participants subject to depressive symptoms in the past. Occurrence of depressive symptoms
for subscale FAF4 is indicated in the small additional figure in a dichotomous fashion (depressive symptoms present in the past or not)
to illustrate comparable effects across groups. Whiskers represent standard error of the mean.
FAF: Questionnaire for Measuring Factors of Aggression; FAF 1: spontaneous aggression (thoughts about aggression against others);
FAF 2: reactive aggression (degree of socially accepted self-assertion); FAF 3: irritability (tolerance to frustration); FAF 4: self-
aggression/depression (dissatisfaction with own personality, self-reproach); FAF 5: inhibition of aggression (ability to regulate
aggressive thoughts). CCH: chronic cluster headache; ECHa: episodic cluster headache in the active phase; ECHi: episodic cluster
headache outside the active period; MIG: migraine; HC: healthy controls.
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Figure 1. Mean FAF subscores given for the different groups (cluster headache, migraine, healthy volunteers). Whiskers represent
standard error of the mean. Results of Bonferroni corrected post hoc t-tests are given as follows: ***< 0.001, **< 0.01, þ< 0.10 (one-
tailed).
FAF: Questionnaire for Measuring Factors of Aggression; FAF 1: spontaneous aggression (thoughts about aggression against others);
FAF 2: reactive aggression (degree of socially accepted self-assertion); FAF 3: irritability (tolerance to frustration); FAF 4: self-
aggression/depression (dissatisfaction with own personality, self-reproach); FAF 5: inhibition of aggression (ability to regulate
aggressive thoughts). CCH: chronic cluster headache; ECHa: episodic cluster headache in the active phase; ECHi: episodic cluster
headache outside the active period; MIG: migraine; HC: healthy controls.
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hypotheses about the order of groups (highest values in
the CCH group, lowest values in the HC group), we
applied one-tailed testing for post hoc comparisons.
To investigate any association of the self-aggression/
depression scale with depressive symptoms we tested
whether subjects reporting previous depressive symp-
toms had increased scores on this scale by means of
an ANOVA.
Bivariate correlations were calculated to examine a
potential relation between the degree of impairment
and the extent of FAF4 scores for self-aggression/
depression (Bonferroni-corrected). Pairwise compari-
sons between the presence of depressive symptoms in
the past and total scores on the HDI were calculated by
means of Mann–Whitney U-tests (non-parametric tests
were used because variables were unevenly distributed).
Results
Clinical data for the headache patients and the controls
are shown in Table 1. FAF data were incomplete and
thus regarded as missing for one chronic and one CH
patient in the active episode. Results for FAF total
score are given in Table 1, for all subscores in Figure 1.
FAF scores
The ANOVA proved to be signiﬁcant for the self-
aggression/depression subscale (F4, 123¼ 5.771,
p< 0.001), but not for the other subscales and the
sum scale, respectively (F4, 123< 1.421, p> 0.230). Due
to violation of variance homogeneity for some scales,
the Kruskal–Wallis H-test was used, the results of
which matched those from the ANOVA. Bonferroni-
corrected post hoc t-tests revealed that for self-aggres-
sion the HC group displayed signiﬁcantly lower values
compared to CCH (p< 0.001) and ECHa (p¼ 0.007),
and marginally lower values compared to the ECHi
(p¼ 0.052) and MIG groups (p¼ 0.099). No signiﬁcant
diﬀerences between the headache patient groups could
be found. At an uncorrected level, CCH patients also
had signiﬁcantly higher values than the ECHi and MIG
groups (see Figure 1).
A signiﬁcant linear trend indicating decreasing levels
of self-aggression/depression from CCH to HC was
found (F1, 123¼ 20.997, p< 0.001, Figure 1). Although
main eﬀects for spontaneous and reactive aggression
and for the sum scale did not reach signiﬁcance,
linear trends were signiﬁcant for these three scales
(F1, 123> 4.246, p< 0.041). At an uncorrected level,
post hoc t-tests reached signiﬁcant diﬀerences (see
Figure 1). Namely, for spontaneous aggression CCH
had higher values than the HC (p¼ 0.012), for reactive
aggression patients with CCH and ECHa had higher
values than the MIG group (p< 0.05), and for the
sum scale aggression CCH had higher values than the
HC group (p¼ 0.018).
Relationship with depressive symptoms
A 2 5 ANOVA was performed with the factors
‘depressive symptoms’ (depressed in the past vs. not
depressed in the past) and ‘group’ (active and inactive
episodic and chronic CH, migraine and healthy con-
trols) for each of the ﬁve FAF subscores and the sum
score to explore a signiﬁcant main eﬀect of ‘depressive
symptoms’. For the dependent variable self-aggression/
depression the analysis revealed a signiﬁcant main eﬀect
for ‘depressive symptoms’ (F1, 113¼ 17.257, p< 0.001)
and group (F4, 113¼ 4.201, p¼ 0.003) while the inter-
action term proved to be non-signiﬁcant
(F1, 113¼ 0.346, p¼ 0.846). That is, all patient groups
and the HC group displayed a pattern of higher
scores in self-aggression/depression when reporting pre-
vious depressive symptoms. The group eﬀect replicates
the general ﬁnding mentioned above. No signiﬁcant
main eﬀects for ‘depressive symptoms’ were found in
the other FAF subscales and the sum scale (Figure 2).
Relationship with impairment
Higher levels of FAF4 scores (self-aggression/depres-
sion) were associated with more severe impairment
measured by the German adaptation of the HDI.
Table 2. Correlation of FAF 4 scores (self-aggression/depres-
sion) with impairment scores in the German adaption of the
Headache Disability Inventory. Pearson’s correlation coefficient is
reported with p-values in parentheses. Results that remain
statistically significant (p< 0.05) after Bonferroni’s correction are
printed in bold
Correlation of FAF4
scores with HDI total HDI emotion HDI function
CCH 0.629 0.677 0.492
(p¼ 0.001) (p< 0.001) (p¼ 0.011)
ECHa 0.654 0.703 0.524
(p¼ 0.001) (p< 0.001) (p¼ 0.009)
ECHi 0.453 0.465 0.410
(p¼ 0.039) (p¼ 0.034) (p¼ 0.065)
MIG 0.436 0.474 0.328
(p¼ 0.033) (p¼ 0.019) (p¼0.117)
Control 0.054 0.055 0.019
(p¼ 0.817) (p¼ 0.813) (p¼ 0.934)
CCH: chronic cluster headache; ECHa: episodic cluster headache in the
active phase; ECHi: episodic cluster headache outside the active period;
MIG: migraine; Control: healthy controls; FAF: Questionnaire for
Measuring Factors of Aggression; HDI: Headache Disability Inventory.
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In the most severely aﬀected groups (CCH and
ECHa) eﬀects were most pronounced (Table 2) and
remained signiﬁcant after correction for multiple
testing.
Relationship of depressive symptoms and
impairment
Participants from the CCH and the ECHa groups, who
reported depressive symptoms in the past, had signiﬁ-
cantly higher levels of impairment (total score) in the
German adaptation of the HDI. In the other groups,
mean values diﬀered numerically but did not reach sig-
niﬁcance (Table 3).
Discussion
The ANOVA proved to be signiﬁcant for the self-
aggression/depression subscale but not for the other
subscales and the sum scale. Post hoc tests revealed
signiﬁcantly increased self-aggression scores for
patients with chronic CH and episodic CH in the
active period compared to healthy volunteers, but
not among the headache groups. Participants who
reported being depressed in the past showed an increase
in the FAF self-aggression/depression subscore.
Additionally, the degree of self-aggression/depression was
associatedwith headache-speciﬁc impairment, especially in
patients with chronic and active episodic CH. This, aˆ his-
tory of depression coincided with greater impairment.
Self-aggressive cognition, depressive symptoms
and impairment
The ‘self-aggression/depression’ domain, as measured
in the FAF, represents feelings of dissatisfaction with
one’s own personality, tendencies of self-reproach and
depressive symptoms. Self-aggression in terms of phys-
ical aggression directed against oneself leading to self-
mutilation or self-inﬂicted injuries are not covered. In a
previous study (4) in the same sample, the lifetime
prevalence of depressive symptoms was found to be
highest in patients with chronic CH, followed by
those with episodic CH and migraine and was shown
lowest in healthy controls. Impairment scores showed a
similar distribution, with highest scores among patients
with active CH, lower scores in the ECHi and MIG
groups and lowest scores in healthy controls. We
could show that patients with active CH and depressive
symptoms in the past suﬀered from signiﬁcantly higher
impairment (as conﬁrmed with the total score of the
HDI) than patients with inactive CH, migraine or
healthy controls. These results are in line with studies
showing elevated incidence of depression in CH
patients (15,17). Increased disability was associated
with increased depression scores (17).
Our ﬁndings corroborate these data as participants
reporting depressive symptoms in the past also dis-
played increased scores in the self-aggression/depres-
sion domain only. In line with these observations, a
positive relationship was found between levels of self-
aggression and scores on the German adaptation of the
HDI (total, emotion and function). Headache patients
with a history of depressive symptoms showed higher
scores of self-reproach and dissatisfaction than those
without symptoms of aﬀective distress in the past;
these were most pronounced for patients in the CCH
and the ECHa groups. These results support the notion
that severely aﬀected patients with CH suﬀer from a
signiﬁcant and complex psychosocial impairment, as
shown in other studies (see (4) for further review).
The factors ‘self-aggression’, ‘depressive symptoms’
and ‘impairment’ correlate with each other and it is
tempting to propose a common pathophysiological
ground.
Higher levels of self-aggression/depression could
at least be partly explained by higher pain densities
in patients with CH. However, it seems noteworthy
that patients with inactive ECH, who have a signiﬁ-
cantly lower current pain density than migraine
patients, had higher levels of self-aggression/depres-
sion than migraine patients. This would argue
against pure pain-related eﬀects.
Table 3. HDI scores depending on depressive symptoms in the
investigated groups. Statistics refer to results of non-parametric
Mann–Whitney U-tests, as distribution of subjects retrospect-
ively reporting depression within the groups was uneven. For
some controls, HDI scores were not available. Significant results
(p< 0.05) are printed in bold
HDI total
score
No depressive
symptoms in
the past
Depressive
symptoms
in the past Statistics
CCH 52.00 24.24 70.93 19.15 p¼ 0.037
(n¼ 12) (n¼ 15)
ECHa 50.44 17.66 82.57 14.13 p¼ 0.001
(n¼ 18) (n¼ 7)
ECHi 37.40 20.91 48.29 33.22 p¼ 0.536
(n¼ 10) (n¼ 7)
MIG 41.19 20.21 40.86 18.72 p¼ 0.671
(n¼ 16) (n¼ 7)
Control 6.06 9.36 1.50 1.92 p¼ 0.275
(n¼ 17) (n¼ 4)
CCH: chronic cluster headache; ECHa: episodic cluster headache in the
active phase; ECHi: episodic cluster headache outside the active period;
MIG: migraine; Control: healthy controls; FAF: Questionnaire for
Measuring Factors of Aggression; HDI: Headache Disability Inventory.
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It is conceivable that the observed psychiatric
comorbidity could be one reason for increased aggres-
sion (14), as found in other studies which focused
mainly on delinquents, patients with personality dis-
orders and patients with suicidal tendencies (35–41).
Interestingly, in our study population patients with
CCH frequently reported suicidal tendencies in the
past. However, we could only ﬁnd increased scores of
internalizing aggressive behaviour that is more asso-
ciated with depressive symptoms/self-reproach,
whereas increased externalizing aggressive behaviour
could not be found. Therefore, any causal attribution
would be speculative and is far beyond the scope of our
study.
Role of the hypothalamus in CH and aggression
Several lines of evidence point to the hypothalamus
as a crucial pathophysiological structure in patients
with CHs. Neuroimaging (22,23) and studies on hor-
monal regulation suggest hypothalamic involvement
(44,45) and consequently deep brain stimulation of
the posterior hypothalamus was successfully estab-
lished in refractory CH (25,26,46–49). Interestingly,
the posteromedial hypothalamus had also been a
target for stereotactic lesions not only in intractable
pain (50) but also in aggressive behaviour (20).
Accidental intraoperative stimulation of the adjacent
‘triangle of Sano’ (region between the posterior
hypothalamic area medially and the medial subtha-
lamic nucleus laterally) led to an outburst of previ-
ously unknown aggressive behaviour in a patient
with Parkinson’s disease (51). In animal experiments,
various parts of the hypothalamus were shown to be
involved in diﬀerent facets of aggression
(18,19,52,53). Accordingly, in humans aggressive
behaviour can be ameliorated by stimulation of the
posterior hypothalamus (54,55).
Although these studies suggest a potential dual role
of the posterior hypothalamus in both aggression and
CH, our results cannot support such a hypothesis.
Aggression in migraine
In the present study, no signiﬁcant diﬀerences were
found for factors of aggression in migraine patients
compared with CH patients and healthy controls
apart from self-aggression/depression. Self-aggression
in migraine patients compared to healthy controls
showed a trend towards higher scores. Likewise, the
positive correlation between self-aggression and impair-
ment reached signiﬁcance on an uncorrected level for
the total score and the emotion subscale on the HDI.
However, a history of depressive symptoms had no
inﬂuence on the level of self-aggression.
Limited data is available for aggression in migraine.
Although not statistically signiﬁcant, the low level of
inhibition of aggression in migraine patients was com-
parable to that of CH patients. This is supported
by studies in adults, adolescents and children with
migraine, which have shown a reduced ability to repress
aggression and anger (56–58). Irritability was highest
on the day before an attack (46%) and still present in
21% of migraine patients interictally (59).
Our ﬁndings of increased self-aggression in migraine
patients are generally in line with the changes observed
for patients with active CH, however they were less
pronounced. Increased levels of depression coincide
with increased self-aggression. Depression has been
extensively reported in migraine (60), but there is only
limited data comparing the prevalence of depression in
diﬀerent primary headaches. As reported elsewhere (4),
in our study population a history of depressive symp-
toms could be found most frequently in patients with
CCH, while those with active and inactive episodic CH
reported depressive symptoms as frequently as those
with migraine. Gesztelyi and co-workers found that
migraine patients had even higher median scores in
Beck’s Depression Inventory (median: 8) than patients
with CH (median: 5) and healthy volunteers (median: 2)
with highest disability in the CH group followed by the
migraine group. However, as a limitation group sizes
diﬀered strongly (61). Although a history of depressive
symptoms was not associated with higher impairment
in our study, quality of life in patients with migraine
was lower than in healthy controls and higher than in
patients with active CH in another study (62).
Limitations
Because of the nature of our study, aggression was only
examined interictally. Therefore, we cannot rule out
that ictal changes within an acute attack were missed.
However, it did not seem feasible to ask the patients
with active CH to complete a questionnaire during an
attack. In future studies, interviewing partners of
patients should also be considered and eventually
searching for signs of aggression on a physical level,
in contrast to the cognitive approach with speciﬁc ques-
tionnaires in this study.
Conclusion
Our ﬁndings did not corroborate signiﬁcantly increased
levels of aggression other than self-aggression in the con-
text of self-reproach as a correlate of depression in
patients with active CH. In line with previous studies,
self-aggression correlated with emotional and functional
measures of impairment with highest disability in the clin-
ically most aﬀected groups with active CH. Likewise, we
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could substantiate a close relationship between reporting
of depressive symptoms and headache-speciﬁc impair-
ment. As our study was not designed to detect a causal
interrelationship between these three dimensions, further
studies will have to address this issue.
As we could not corroborate any signiﬁcant eﬀect
beyond self-aggression, our data do not support a
dual role of the hypothalamus in the generation of
both aggression and CH. As a clinical consequence,
self-aggression in the context of depression should be
clinically monitored and therapeutically targeted.
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